Trading Ideas

Yahoo Finance’s Alexis Christoforous and Brian Sozzi speak with Sorrento Therapeutics Founder & CEO Dr. Henry Ji about the company’s experimental antibody STI-1499. …read more […]

Target’s sales surged in the first quarter, fueled by people spending during the coronavirus outbreak. Sucharita Kodali, Forrester Research Retail analyst, joins Yahoo Finance’s Alexis Christoforous and Brian Sozzi to discuss the retailers earnings report and how it compares to its competitors. …read more […]

Clorox Co. (CLX) declared a quarterly dividend of $1.11 per share on the company’s common stock, up 5% from the previous $1.06 per share dividend. Shares in the maker of bleach and disinfecting wipes appreciated 2.4% to $206.51 in pre-market U.S. trading.The dividend is payable on Aug. 14 to stockholders of record as of the close of business on July 29.”We are pleased to raise our dividend by 5%, building on nearly 20 consecutive years of dividend increases,” said Clorox Chairman and CEO Benno Dorer. “As we continue to deliver healthy cash flows, our ongoing priority is to invest in …read more […]

Yahoo Finance’s Alexis Christoforous and Brian Sozzi discuss Target’s first quarter earnings, and break down what Target CEO Brian Cornell had to say about the results. …read more […]

Luckin Coffee said on Tuesday that Nasdaq had notified the company of plans to delist it from the U.S. stock exchange, a month after the company disclosed that some employees had fabricated sales accounts. Nasdaq’s notice comes as the exchange renews its focus on auditing standards. In its delisting notice, the bourse cited public interest concerns raised by the fabricated transactions and Luckin’s failure to disclose material information. …read more […]

The U.S. motorcycle maker, which closed its U.S. plants in March due to the coronavirus outbreak, may not ship any additional new motorcycles this year to about 70% of its 698 dealers in the country, the report said https://on.wsj.com/2Tn92JP. The company did not immediately respond to Reuters request for comment. Harley would reopen its plants in Wisconsin and Pennsylvania and accelerate production in phases that would be limited to bestselling models and palette of colors and without customizable features for the rest of the year, the report said. …read more […]

Nio, Inc. (NYSE: NIO) is a Chinese holding company. It specializes in the design, manufacture, and the sale of electric vehicles (EVs). Therefore, investors may see Nio stock as a good alternative play to Tesla. Of course, Tesla is the famed EV manufacturer headed by the controversial mogul Elon Musk.
Investment U expert and Manward Press founder Andy Snyder calls Nio “The Tesla of China.” But Tesla will cost you over a whopping $800 for one share. On the other hand, Nio is a penny stock. And it sells for approximately a mere $3 on the New York Stock …read more […]

“Last quarter was unlike anything I’ve ever seen,” Chief Executive Brian Cornell told reporters. Stay-at-home orders imposed to contain the virus powered a 141% jump in Target’s online comparable sales, accounting for almost all of its same-store sales growth. At the start of the quarter, Target, like Walmart, benefited from customers stockpiling staples and cleaning products, but as the lockdown extended and the stimulus checks arrived, demand rose for discretionary items including apparel. …read more […]

A new forecast shows the damaged economy leading Trump to resounding defeat in November. …read more […]

“We saw antibody responses that do many of the things we would want to see in an eventual vaccine,” said Dr. David Weiner, director of the vaccine and immunotherapy center at the Wistar Institute, which has collaborated with Inovio. Inovio, which began human testing of its vaccine in April, said preliminary results from that trial are expected in June. …read more […]

More money. More money. More money.
Everywhere we look, folks are calling for more money. From the head of the Federal Reserve telling Congress to spend as much as it can to business owners begging Trump to keep the free money flowing.
By all measures, it’s working.
It’s no coincidence that stocks soared on Monday… just a day after Congress conjured up another $3 trillion worth of stimulus proposals.
The action we saw on Monday was quite good. Investors with the brains to play this mess are doing incredibly well.
For example, we wrote our Alpha Money Flow subscribers on Monday afternoon and told them …read more […]

Target’s first quarter 2020 earnings are out. Here’s what you need to know. …read more […]

AstraZeneca Plc’s (AZN) and Merck Co.’s (MRK) Lynparza drug has received a green light from the U.S. Food and Drug Administration (FDA) for the treatment of patients with advanced prostate cancer.The FDA approval was awarded following results from a Phase III trial, which found that the Lynparza drug treatment reduced the risk of disease progression or death by 66%.Prostate cancer is the second-most common cancer type in men and despite an increase in the number of available therapies for men suffering from the disease, five-year survival remains low.Lynparza is a first-in-class PARP inhibitor, which is a targeted treatment to potentially …read more […]

Oil prices firmed on Wednesday on signs of improving demand and a drawdown in U.S. crude inventories, but worries over the economic fallout from the coronavirus pandemic and weak refining margins capped gains. Brent crude futures were up 51 cents, or 1.47%, at $35.16 per barrel at 0928 GMT. U.S. West Texas Intermediate (WTI) July crude futures were up 22 cents, or 0.69%, at $32.18 a barrel. …read more […]

(Bloomberg) — ByteDance Ltd.’s valuation has risen at least a third to more than $100 billion in recent private share transactions, people familiar with the matter said, reflecting expectations the owner of video phenom TikTok will keep pulling in advertisers despite the Covid-19 pandemic.Stock in the world’s most valuable startup has changed hands recently at a price that suggests its value has risen more than 33% from about $75 billion during a major round of funding two years ago, the people said, requesting not to be named because the issue isn’t public. Some of those transactions valued the Chinese company …read more […]